-
participation in research, teaching & administration, which means: Experience in synthetic organic/ medicinal chemistry / drug design and a passion for drug discovery Experience in advanced organic chemical
-
against cancer. Within the School, the Comprehensive Cancer Centre (CCC) integrates molecular discovery, drug-development pipelines and patient-facing trials, with strengths in personalised medicine, immuno
-
of toxicity assay and translational criteria in drug development. Basic knowledge of one or more aspects of molecular design in therapeutic radiopharmaceuticals and molecular imaging probes. Knowledge in
-
of Biomedical Engineering and Imaging Sciences is a cutting-edge research and teaching School dedicated to development, translation and clinical application within medical imaging and computational modelling
-
relevant for drug discovery analysis pipelines, trial design and operational efficiency. Led by Professor Chris Holmes, and with scientific oversight from Oxford Principal Investigators and GSK scientists